PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

Conditions: Androgen Axis Suppression; Prostatectomy; Prostate Cancer Interventions: Drug: Apalutamide; Drug: Androgen Deprivation Therapy Sponsors: M.D. Anderson Cancer Center; Janssen Scientific Affairs, LLC Not yet recruiting

https://clinicaltrials.gov/study/NCT06274047

Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials